Alan Lotvin

CIK: 0001472795

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PROK

PROKIDNEY CORP.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

PROK
PROKIDNEY CORP.
May 28, 2026
Award(A)
Director stock option (right to buy)
Direct
135K shares-
PROK
PROKIDNEY CORP.
May 29, 2025
Award(A)
Director stock option (right to buy)
Direct
125.9K shares-

		Type	Shares	Price		Ownership
May 28, 2026	PROK PROKIDNEY CORP.	Award(A) Director stock option (right to buy)	135,000	-	-	Direct
May 29, 2025	PROK PROKIDNEY CORP.	Award(A) Director stock option (right to buy)	125,862	-	-	Direct

1-2 of 2 transactions

About Lotvin Alan

Lotvin Alan (SEC CIK 0001472795) files insider reports with the SEC as Director of PROKIDNEY CORP. (PROK).

Signal8 holds 2 ownership filings by Lotvin Alan, all Form 4s, filed between Jun 2, 2025 and May 29, 2026. Those filings report 2 transactions, from May 29, 2025 to May 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lotvin Alan's filings is in WINSTON SALEM, NC.

Recent filings by Lotvin Alan

May 28, 2026: Grant or award of PROK derivative securities (Form 4, code A).
May 29, 2025: Grant or award of PROK derivative securities (Form 4, code A).

Other insiders filing for PROKIDNEY CORP. (PROK)

Weber Darin J., Chief Regulatory Officer
Pereira Brian JG, Director
Locke Kenneth Thomas, Chief Technical Officer
Girolamo Todd C, Chief Legal Officer
Jimenez Santos Jose Ignacio, Director
Fox Jennifer A., Director

How to read Form 4 transaction codes